CD274 and neoplasm: Two measures of PD-L1 positivity are currently used: the tumor proportion score (TPS), which is the percentage of tumor cells with membranous PD-L1 expression, and combined positive score (CPS), which is the percentage of PD-L1 positive cells (tumor cells, macrophages, and lymphocytes) among all tumor cells.